Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force

J Crohns Colitis. 2020 Oct 21;14(14 Suppl 3):S785-S790. doi: 10.1093/ecco-jcc/jjaa147.


Infusion centres are a central part in the management of patients with inflammatory bowel disease [IBD] and could be a source of transmission of SARS-COV-2. Here we aimed to develop global guidance for best practices of infusion centres for IBD patients and to determine the impact of the COVID-19 pandemic on these centres. Under the auspices of the International Organization for the Study of Inflammatory Bowel Disease [IOIBD], a task force [TF] was formed, an online survey was developed to query infusion centre protocols during COVID-19, and recommendations were made, based on TF experience and opinion. Recommendations focus mainly on patients screening, infusion centres re-organization, personnel protection, and protocol modifications such as shortening infusion duration or replacing it with subcutaneous alternatives. Implementing these recommendations will hopefully reduce exposure of both IBD patients and care givers to SARS-COV-2 and improve the function and safety of infusion centres during the COVID-19 pandemic as well as potential future threats.

Keywords: COVID; biologics; infusion centers.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Advisory Committees
  • Ambulatory Care / methods
  • Ambulatory Care / standards*
  • Ambulatory Care Facilities / standards*
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • Clinical Protocols
  • Coronavirus Infections / complications
  • Coronavirus Infections / prevention & control*
  • Drug Administration Schedule
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use
  • Global Health
  • Health Care Surveys
  • Humans
  • Infection Control / methods
  • Infection Control / standards*
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / drug therapy*
  • Infusions, Intravenous
  • Maintenance Chemotherapy / methods
  • Maintenance Chemotherapy / standards
  • Pandemics / prevention & control*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / prevention & control*
  • SARS-CoV-2


  • Anti-Inflammatory Agents
  • Gastrointestinal Agents